BNR - Company ID 0001792267
The table below shows Burning Rock Biotech Ltd's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$4.07M | -$12.64M | -$36.03M | -$66.23M | -$74.99M | -$11.27M |
| Capital expenditure | $751.00K | $742.00K | $1.14M | $8.99M | $32.06M | $9.24M |
| Investing cash flow | -$628.00K | -$604.00K | -$1.31M | -$1.08M | $12.82M | -$16.75M |
| Dividends paid | - | - | - | - |
Burning Rock Biotech Ltd reported operating cash flow of -$4.07M for fiscal year 2025. That is up 67.8% from -$12.64M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$11.27M (FY 2020) to -$4.07M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | $0.00 | $0.00 |
| Financing cash flow | $272.00K | -$10.00K | -$6.88M | -$12.50M | -$8.30M | $331.91M |